Audience

Read by all 50 of the biggest Pharma companies, like Pfizer and Novartis, as well as thousands of innovative, clinical-stage biotechs.

OUR PLATFORMS draw

243k+
daily email subscribers
700K+
unique monthly visitors
1.8M
average monthly page views
70K+
event registrations

OUR SUBSCRIBERS count

OUR SUBSCRIBERS span

OUR TOP STORIES include

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices
May 7, 2025
FDA picks controversial doctor Vinay Prasad as CBER director, in about-face from Marks
May 6, 2025
'Go ahead and do it': Top RFK Jr. deputy dares drugmakers that might pull manufacturing over new price pressure
May 15, 2025
Trump administration reveals 'most favored nation' drug price country targets
May 20, 2025
White House threatens ‘most favored nation’ plan to lower US drug prices, but many questions remain
May 12, 2025

Get started

Connect with us to request a media kit and learn more about rates and availability.

Julie O'Meara
Julie O'Meara
Executive Director, Brand Partnerships, Endpoints News
Melissa Nazzaro